CAMBRIDGE, Mass., Aug. 3 /PRNewswire/ -- Gene Network Sciences, Inc. (GNS) today announced that it has entered into an agreement with CombinatoRx, Incorporated (CRXX) to contribute to ongoing mechanism of action research for synergistic combinations in development. Financial terms of the agreement were not disclosed.
